or Try an Advanced Search...

    Technical Analysis for NBTX - Nanobiotix S.A.

    Grade Last Price % Change Price Change
    D 5.91 0.17% 0.01
    NBTX closed up 0.17 percent on Thursday, April 25, 2024, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical NBTX trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    20 DMA Resistance Bearish 0.17%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.17%
    MACD Bullish Signal Line Cross Bullish 0.17%
    NR7 Range Contraction 0.17%
    Narrow Range Bar Range Contraction 0.17%
    Inside Day Range Contraction 0.17%
    Older End-of-Day Signals for NBTX ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 2 days ago
    Possible Inside Day 2 days ago
    60 Minute Opening Range Breakout 2 days ago
    Gap Up Partially Closed 2 days ago
    Gapped Up (Partial) 2 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    NBTX Chart by TradingView
    Basic chart:

    Profile

    Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

    Is NBTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Nanobiotix reports FY results
    Apr 24 NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
    Apr 17 NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
    Apr 13 11 Best Nanotechnology Stocks To Invest In
    Apr 2 Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
    Mar 18 Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Mar 11 EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
    Mar 6 Nanobiotix to Present at Upcoming Investor Conferences in March
    Jan 31 Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
    Jan 30 Baillie Gifford Bolsters Stake in Nanobiotix SA
    See more NBTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 11.0
    52 Week Low 1.75
    Average Volume 21,473
    200-Day Moving Average 7.16
    50-Day Moving Average 6.33
    20-Day Moving Average 5.96
    10-Day Moving Average 5.67
    Average True Range 0.37
    RSI (14) 47.64
    ADX 17.93
    +DI 23.29
    -DI 16.90
    Chandelier Exit (Long, 3 ATRs) 5.48
    Chandelier Exit (Short, 3 ATRs) 6.25
    Upper Bollinger Bands 6.67
    Lower Bollinger Band 5.26
    Percent B (%b) 0.46
    BandWidth 23.75
    MACD Line -0.20
    MACD Signal Line -0.22
    MACD Histogram 0.0222
    Fundamentals Value
    Market Cap 278.43 Million
    Num Shares 47.1 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -3.27
    Price-to-Sales 51.51
    Price-to-Book 65.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.91
    Resistance 3 (R3) 5.91 5.91 5.91
    Resistance 2 (R2) 5.91 5.91 5.91 5.91
    Resistance 1 (R1) 5.91 5.91 5.91 5.91 5.91
    Pivot Point 5.91 5.91 5.91 5.91 5.91
    Support 1 (S1) 5.91 5.91 5.91 5.91 5.91
    Support 2 (S2) 5.91 5.91 5.91 5.91
    Support 3 (S3) 5.91 5.91 5.91
    Support 4 (S4) 5.91